MDMA-assisted psychotherapy for the treatment of PTSD
- PMID: 33053043
- PMCID: PMC8023168
- DOI: 10.1590/1516-4446-2020-0020
MDMA-assisted psychotherapy for the treatment of PTSD
Conflict of interest statement
CMR reports no conflicts of interest. WMM has received research support from Cervel Neurotherapeutics, NeoSync, Neuronetics, and Soterix; has served as a consultant for Signant Health; and receives royalties from Oxford University Press.
References
-
- Steenkamp MM, Litz BT, Marmar CR. First-line Psychotherapies for Military-Related PTSD. JAMA. 2020 Jan 30 doi: http://10.1001/jama.2019.20825. Online ahead of print. - DOI - PubMed
-
- McDonald WM, van Rooij SJ. Targeting PTSD. Am J Psychiatry. 2019;176:894–6. - PubMed
-
- Jardim AV, Jardim DV, Chaves BR, Steglich M, Ot'alora GM, Mithoefer MC, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil. Braz J Psychiatry. 2021;43:181–5. - PMC - PubMed
-
- Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. 2020;177:391–410. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical